Basic Pharma
Harry Relouw is an experienced professional who has held various finance and management positions in different companies within the pharmaceutical and technology industries. Harry is currently serving as the General Manager & CFO at Basic Pharma Group, a pharmaceutical company focused on niche products. Prior to this, Harry was the Chief Financial Officer at Matisse Pharmaceuticals, where Harry played a key role in in-licensing a patent for a novel treatment for sepsis. Harry has also worked in finance and control roles at companies such as Prosensa Therapeutics B.V., Ericsson, AkzoNobel, DSM, and Rhein Biotech NV. Harry holds a post graduate degree in Finance from Open Universiteit.
This person is not in any teams
Basic Pharma
1 followers
Basic Pharma is a pharmaceutical company focused on the development, licensing, registration, manufacturing and commercialisation of pharmaceutical niche products. And we deliver a full service package to the Pharmaceutical, Biotech and Medical Device industry. The company mainly produces sterile and non-sterile, semi solid and liquid preparations and acts as a service provider for academic centres, biotech start-ups and the pharmaceutical industry. By developing improved formulations or delivery methods, the company adds value to existing off patent products and is able to rapidly introduce these products through its flexible manufacturing facilities and well established distribution channels. Basic Pharma has the combined expertise to ensure you get the required service and products in time at the agreed quality level. As an experienced full service provider, we offer a wide range of services for clients all over the world. Whether you need product development support, registration support or would like to outsource your (IMP)-GMP production, you can rely on us. For more information on Basic Pharma, please visit our website: www.basicpharma.nl